The Scottish Medicines Consortium (SMC) has accepted ustekinumab for use in patients with active psoriatic arthritis who have failed on, or are unsuitable for, treatment with an anti-tumour necrosis factor (TNF) drug. www.papaa.org http://www.scottishmedicines.org.uk/SMC_Advice/Advice/944_14_ustekinumab_Stelara/Briefing_note_ustekinumab_Stelara

Copper screen panels are part of a manufacturer's engineered system. The details shown here illustrate the main concepts in the design of copper screen panels.